XSWX:QGEN (Netherlands)  
Qiagen NV logo

Qiagen NV

CHF 41.45 (0%) Apr 1
On watch
P/E:
25.05
P/B:
3.45
Market Cap:
CHF 10.25B ($ 10.98B)
Enterprise V:
CHF 10.63B ($ 11.38B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap CHF:
10.25B
Market Cap $:
10.98B
PE Ratio:
25.05
Avg Vol (2-Month):
-
Enterprise Value CHF:
10.63B
Enterprise Value $:
11.38B
PB Ratio:
3.45
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).
Name Current Vs Industry Vs History
Cash-To-Debt 0.82
Equity-to-Asset 0.51
Debt-to-Equity 0.69
Debt-to-EBITDA 2.75
Interest Coverage 11.36
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.49
Distress
Grey
Safe
Beneish M-Score -2.88
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
12-1 Month Momentum % 5.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.84
Quick Ratio 1.62
Cash Ratio 1.26
Days Inventory 151.67
Days Sales Outstanding 57.05
Days Payable 41.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2

Financials (Next Earnings Date:2023-02-08 Est.)

XSWX:QGEN's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 2,106.856
EPS (TTM) (CHF) 0
Beta 0
Volatility % 8.32
14-Day RSI 0
14-Day ATR (CHF) 0
20-Day SMA (CHF) 0
12-1 Month Momentum % 5.07
52-Week Range (CHF) 39.45 - 41.45
Shares Outstanding (Mil) 227.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Qiagen NV Filings

Document Form Filing Date
No Filing Data

Qiagen NV Analysis

Share your research